Justin Thompson
Corporate Officer/Principal chez CINCOR PHARMA, INC.
Postes actifs de Justin Thompson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CINCOR PHARMA, INC. | Corporate Officer/Principal | 01/08/2021 | - |
Historique de carrière de Justin Thompson
Anciens postes connus de Justin Thompson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
CincyTech LLC
 CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio. | Private Equity Analyst | 25/11/2009 | - |
Formation de Justin Thompson
| Washington University in St. Louis | Undergraduate Degree |
| University of Cincinnati (Ohio) | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Private Equity Analyst | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
CincyTech LLC
CincyTech LLC Investment ManagersFinance CincyTech LLC (CincyTech) is a venture capital firm founded in 2007. The firm is headquartered in Cincinnati, Ohio. | Finance |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Justin Thompson
- Expérience
